glp-1 drug market Analogues Size, Share & Growth Drivers By 2034 GLP-1 Receptor Agonist Market |
Description
At 8mg, the glucagon receptor stimulation is strong enough to produce the tingling and altered skin sensitivity reported in trials

doi: 10.1016/j.jhepr.2019.07.002 138 PatelVJoharapurkarAKshirsagarSSutariyaBPatelMPatelHet al
Efficacy and safety of GLP-1 receptor agonists in patients with metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis of randomized controlled trials
Clinicians should evaluate individual risk factors, comorbidities, and contraindications when choosing patients for treatment, balancing possible benefits with associated dangers

Endocrinology (1999) 140:535663
